Financial Performance & Growth - DTI's Q1 2025 revenue reached $42.9 million, reflecting broad scope and scale[13] - Q1 2025 revenue increased by 16% quarter-over-quarter, despite a 6% global rig count decline[13] - The company anticipates Adjusted Free Cash Flow between $14 million and $19 million for FY 2025[95] - DTI expects to double revenue contribution from the Eastern Hemisphere in FY 2025[96] Geographic Footprint - Western Hemisphere accounted for 89% of Q1 2025 revenue, while the Eastern Hemisphere contributed 11%[13] - Tool rental in the Eastern Hemisphere saw a significant increase of 968% quarter-over-quarter[86] - Over 60% of all drilling rigs in North America utilize DTI tools and equipment[85] Strategic Initiatives - DTI expanded its ABL Credit Facility from $60 million to $80 million and added a $25 million term loan maturing in March 2029[42] - The company has grown its portfolio from 2 to 16 patented products, supported by approximately 150 active patents[42] - DTI authorized a $10 million share repurchase program[45] M&A and Synergies - DTI is on track to achieve 100% of the $4.5 million in previously announced SDPI synergies by August 2025[59] - The company identified additional synergies in excess of the targeted amount from acquisitions[59]

Summary of BrightSpring Health Services (BTSG) Conference Call Company Overview - **Company**: BrightSpring Health Services (BTSG) - **Industry**: Healthcare, specifically home and community health care and pharmacy services Key Points and Arguments Financial Performance - **Q1 Performance**: The company reported a strong Q1, beating expectations and raising guidance, primarily driven by specialty pharmacy performance [2][4] - **Historical Growth**: The company has achieved a mid-teens CAGR in EBITDA and revenue over nearly a decade, with broad-based growth across service lines [4][5] - **Volume Growth**: Volume growth is supported by quality service across all lines, operational efficiencies, and accretive mergers and acquisitions (M&A) [5][6] Specialty Pharmacy Growth - **Oncology and Rare Diseases**: Specialty pharmacy, particularly in oncology and rare diseases, has seen significant growth, with a reported 30% growth year-over-year for the last three years [9][10] - **Innovation in Therapies**: Continuous innovation in therapies is driving demand, with expectations of 12 to 18 new products entering the market in the next 18 months [13] Service Lines and Market Dynamics - **Home and Community Focus**: BrightSpring aims to be a leading provider in home and community health care, with strong demand for services [6][17] - **Provider Business Growth**: The provider business experienced around 10% year-over-year growth, even with fewer days in the quarter compared to the previous year [7] - **Pharmacy Services**: The pharmacy business is expected to grow in the mid-single digits, with potential for double-digit growth in specific areas like infusion and specialty oncology [25][26] M&A Strategy - **Acquisition Focus**: The company has executed several smaller tuck-in acquisitions and plans to continue this strategy, particularly in home health, hospice, and rehab [15][58] - **Community Living Divestiture**: The divestiture of the community living business is expected to close by the end of the year, which will help improve leverage ratios [54][55] Regulatory Environment - **Impact of Inflation Reduction Act (IRA)**: The IRA has both positive and negative implications for the company, particularly concerning drug pricing and access to medications [35][38] - **Tariffs on Drugs**: Potential tariffs on drugs are being monitored, with the company confident in its supply chain resilience due to a significant portion of drugs being sourced domestically [42][46] Operational Efficiency - **EBITDA Margin Target**: The company targets a 6% EBITDA margin, focusing on lean operations and technology to enhance efficiency across business lines [34] - **Integrated Care Opportunities**: The company is exploring integrated care models that combine various services to improve patient outcomes and reduce hospitalizations [31][33] Future Outlook - **Leverage Reduction**: The company aims to reduce leverage to around three times by the end of the year, supported by cash generation and growth [55][56] - **Market Positioning**: BrightSpring is positioned to leverage its scale and operational capabilities to navigate regulatory changes and market dynamics effectively [50][51] Additional Important Insights - **Quality and Compliance**: The company emphasizes its commitment to quality and compliance, which has resulted in better performance metrics compared to industry averages [22] - **Patient-Centric Approach**: The focus on delivering high-quality, patient-centered services is seen as a key driver for growth and market share [20][21]

Financial Data and Key Metrics Changes - Revenue for Q1 2025 was $4,500,000, a decrease of approximately 23% compared to $5,800,000 in Q1 2024, primarily due to the discontinuation of TrustCo's operations and a softening of customer shipments [4][12] - Gross profit decreased by $800,000 to $1,500,000 in Q1 2025 from $2,300,000 in Q1 2024, with gross margin at 33% in Q1 2025 compared to 39% in Q1 2024 [12][13] - Operating expenses were reduced by approximately 28% to $2,100,000 in Q1 2025 from $2,900,000 in Q1 2024 [5][13] - The net loss for the quarter was $600,000, or a loss of $0.05 per diluted share, consistent with Q1 2024 [13] Business Line Data and Key Metrics Changes - The decline in revenue was most pronounced in premium services, which were down 47% compared to the same quarter last year [4] - Improvements in gross margin were noted in proactive services within the Precision Logistics segment, indicating potential for organic growth [5] Market Data and Key Metrics Changes - The overall market for e-commerce is experiencing a softening, impacting customer confidence and spending, which in turn affects revenue from proactive customers [46][47] Company Strategy and Development Direction - The company is focusing on three elements for organic growth: optimizing direct customer marketing, developing relationships with additional freight carriers, and integrating with technology platforms related to e-commerce [7][9][10] - The company is exploring both transformative and tuck-in acquisitions to enhance shareholder value, with a strong balance sheet and cash flow supporting these initiatives [10][31] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenges posed by the current macroeconomic environment but remains optimistic about the potential for growth through strategic initiatives and a strong cash position [5][58] - The company is not providing specific revenue guidance for the year but anticipates a challenging comparison in Q2 due to prior customer losses [37] Other Important Information - Nancy Meyers, CFO, announced her retirement, with Jennifer Colo set to take over the role, ensuring a smooth transition [16][19] - The company had a cash balance of $5,700,000 at the end of Q1 2025, an increase from $2,800,000 at the end of 2024, with no bank debt [6][14] Q&A Session Summary Question: Capital allocation priorities and organic vs external growth - Management indicated that investments for organic growth are funded by the business and do not require cash from reserves, focusing on integrating with e-commerce platforms [25][26] Question: Revenue generation for the authentication business - The revenue for the authentication business in the quarter was $26,000 [33] Question: Revenue expectations for the rest of the year - Management expects challenging revenue comparisons in Q2 but anticipates easier comparisons in the second half of the year, with a focus on proactive revenue [37][40] Question: Update on new customers and their performance - New customer additions have slowed, and while there is no significant loss of customers, overall softening is observed across the customer base [46][48] Question: Strategic discussions regarding the ink business - Management is open to synergistic acquisitions in the ink business but sees higher value potential in Precision Logistics [50][51] Question: Overall comfort with the company's position compared to a few months ago - Management feels optimistic about the company's opportunities, citing a strong balance sheet and a receptive market environment for new ideas [55][58]

Growth on the Horizon November 2024 May 2025 www.edrsilver.com TSX: EDR | NYSE: EXK TSX: EDR | NYSE: EXK www.edrsilver.com TSE: EDR | NYSE: EXK Cautionary Note This presentation contains "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward-looking information" within applicable Canadian securities legislation. Such forward-looking statements and information herein include but are not limited to statements regarding Endeavour's acq ...

Financial Data and Key Metrics Changes - Total client assets at the end of March were $171 billion, slightly down from the start of the year, with average AUM approximately 1% lower compared to the fourth quarter [6] - Revenue for the first quarter was $219.6 million, down about 5% from the fourth quarter due to lower average AUM and fewer days in the quarter, but year-over-year revenue was higher [21][22] - Adjusted earnings per diluted share with tax benefit was $1.36, marking the second highest quarterly EPS in company history and a record for any first quarter [9][30] - Adjusted EBITDA was $116 million with a margin of 53%, reflecting a 90 basis point expansion from the first quarter of the previous year [30] Business Line Data and Key Metrics Changes - Gross sales increased by 41% from the last quarter, reaching $9.3 billion, the highest level of quarterly gross sales in three years [6] - The ETF AUM increased to over $13 billion, a 28% increase during the quarter and up 67% year-over-year [8] - The Amundi acquisition resulted in a doubling of fixed income AUM as a percentage of total assets from 14% to 28% [11] Market Data and Key Metrics Changes - The company ended the quarter with $44 billion of AUM sourced from clients outside the U.S., representing 15% of total AUM, compared to less than 5% previously [12][24] - Pioneer Investments generated positive net long-term flows of $1.7 billion in the first quarter, which is not included in the company's numbers due to the transaction closing on April 1 [13][27] Company Strategy and Development Direction - The company is strategically investing in distribution channels, data, technology, marketing, and intermediary partnerships to enhance organic growth [10][19] - Plans for several ETF launches in 2025 are underway, with a focus on expanding the product lineup [9][19] - The company aims to maintain a long-term margin target of 49%, despite short-term integration costs from the Amundi acquisition [45] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the underlying activity around flows, viewing the two large redemptions as one-time events that should not distort organic growth progress [7] - The company is well-positioned for organic growth with a larger sales force and enhanced resources dedicated to distribution efforts [19][66] - Management anticipates a potential acquisition announcement in 2025, leveraging the improved balance sheet and cash position [58] Other Important Information - The company returned $39 million to shareholders during the first quarter and increased the quarterly dividend to $0.49 per share [22] - The net leverage ratio remained steady at 1.7 times, with cash on hand increasing to $176 million [22][31] Q&A Session Summary Question: Can you elaborate on the rollout of new products outside the U.S.? - Management indicated that they are working with Amundi to identify successful products for international markets, with launches expected in the latter half of 2025 [35][38] Question: How will margins evolve in the near term? - Management confirmed that while margins are currently at 53%, they expect a slight decline during integration efforts, but remain bullish on achieving long-term targets of 49% [42][45] Question: What is the state of the acquisition pipeline? - Management stated that the company is in a strong position to execute sizable transactions and is leaning towards larger scaled opportunities [56][58] Question: How are fixed income and solutions performing in volatile markets? - Management noted that the fixed income platform has expanded and performed well, with positive net flows observed in the first quarter [64][66] Question: Have there been any dissynergies from the Amundi acquisition? - Management reported no dissynergies from the Amundi acquisition, highlighting positive net flows from Pioneer Investments [72][74] Question: What investments are being made to enhance organic growth? - Management detailed significant investments in sales, marketing, and data technology to support organic growth, with success measured by growth in business [84][87] Question: How important are alternative investment products for future acquisitions? - Management acknowledged the importance of alternative investments and is evaluating various strategies to incorporate them into the platform [90][92] Question: What is the rationale behind the change in dividend policy? - Management explained that the change allows for more opportunistic increases while prioritizing capital for acquisitions and growth [96][98]

Financial Data and Key Metrics Changes - Total client assets at the end of March were $171 billion, slightly down from the start of the year, with average AUM approximately 1% lower compared to the fourth quarter [4] - Revenue for the first quarter was $219.6 million, down about 5% from the fourth quarter due to lower average AUM and fewer days in the quarter [18] - Adjusted earnings per diluted share with tax benefit was $1.36, marking the second highest quarterly EPS in company history [6][18] - Adjusted EBITDA was $116 million with an EBITDA margin of 53%, reflecting a 90 basis point expansion from the first quarter of the previous year [28] Business Line Data and Key Metrics Changes - Gross sales increased by 41% from the last quarter, reaching $9.3 billion, the highest level of quarterly gross sales in three years [4] - The ETF AUM increased to over $13 billion, a 28% increase during the quarter and up 67% year-over-year [5] - The Amundi U.S. business generated positive net long-term flows of $1.7 billion in the first quarter, which is not included in the current numbers due to the transaction closing on April 1 [11] Market Data and Key Metrics Changes - The proportion of retail assets under management rose, with $44 billion sourced from clients outside the U.S., representing 15% of total AUM compared to less than 5% previously [10] - The investment performance remained strong, with 67% of mutual fund and ETF assets earning four or five-star ratings from Morningstar [17] Company Strategy and Development Direction - The company is strategically investing in distribution channels, data, technology, marketing, and intermediary partnerships to enhance organic growth [7][8] - Plans for several ETF launches in 2025 are underway, with a focus on expanding the product lineup [6][10] - The company aims to maintain a long-term margin target of 49%, despite short-term fluctuations due to integration efforts [44] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the underlying activity around flows, viewing the recent large redemptions as one-time events that should not distort ongoing growth [5] - The company is encouraged by discussions regarding ongoing diligence activities and sees potential for additional strategic growth opportunities [8][56] Other Important Information - The company increased its quarterly dividend to $0.49 per share, payable on June 25, and anticipates moving back to an annual increase cycle [19][95] - The leverage ratio improved significantly following the Amundi transaction, enhancing financial flexibility [8][29] Q&A Session Summary Question: Can you elaborate on the rollout of new products outside the U.S.? - The company is working with Amundi to identify products for international markets, with launches expected in the latter half of 2025 [35][39] Question: How will margins evolve in the near term? - Margins may see a slight decline during integration efforts, but the long-term target remains at 49% [44][45] Question: What is the current state of the acquisition pipeline? - The company is in a strong position to execute sizable transactions and is leaning towards larger scaled opportunities [56][57] Question: Have there been any dissynergies from the Amundi acquisition? - No dissynergies have been observed; the combined business has resonated well in the market [72] Question: What investments are being made to enhance organic growth? - Significant investments in sales, marketing, and data technology are being made to support organic growth [84][85] Question: How important are alternative investment products for future acquisitions? - Alternatives are important, and the company is evaluating various ways to incorporate them into its offerings [88][89]

INVESTOR PRESENTATION May 2025 Forward-looking statements involve known and unknown risks and uncertainties that may cause future results to differ materially from those suggested by the forward-looking statements. Such risks and uncertainties include, but are not limited to the following; our business, operations, customers, suppliers nd employees; general economic conditions in the areas of the United States in which the Company's customers are located; changes in the market where uniforms are worn, where ...

FY2025 Second Quarter Earnings Three Months Ended 3.31.25 May 8, 2025 CONFIDENTIAL & PROPRIETARY © Copyright 2025 DLH Holdings Corp. All Rights Reserved. 1 President and Chief Executive Officer Kathryn JohnBull Chief Financial Officer 2 CONFIDENTIAL & PROPRIETARY © Copyright 2025 DLH Holdings Corp. All Rights Reserved. Forward-Looking Statements Call Participants Zach Parker "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking sta ...

Financial Data and Key Metrics Changes - The company reported adjusted operating earnings per share of $2.00 in Q1 2025, reflecting a 13% increase year-over-year [11] - Generated approximately $200 million in cash during the quarter, exceeding the 90% target [12] - GAAP net income was below cash generation due to non-cash items [12] Business Line Data and Key Metrics Changes - In Wealth Solutions, adjusted operating earnings were $207 million, an 11% year-over-year growth, driven by higher fee-based revenues and the acquisition of OneAmerica, which added $60 billion in assets [13] - Investment Management generated $41 million in adjusted operating earnings, with net inflows of $7.7 billion, representing 2.5% organic growth [15] - Health Solutions reported adjusted operating earnings of $46 million, with improved margins and a focus on stabilizing stop-loss experience [17] Market Data and Key Metrics Changes - Wealth Solutions achieved defined contributions organic net flows of approximately $30 billion, with strong performance in healthcare and government markets [6] - Investment Management's net cash flows were broad-based across institutional and retail markets, with significant demand for fixed income and private assets [7][15] - The company noted a strong pipeline supporting long-term organic growth targets of over 2% [8] Company Strategy and Development Direction - The company emphasizes a capital-light business model that generates diverse revenue streams and consistent free cash flow [5] - Focus on innovative workplace solutions and top-notch asset management to create long-term value for stakeholders [5] - Plans to enhance retail wealth management capabilities through modest investments and hiring additional advisors [53][56] Management's Comments on Operating Environment and Future Outlook - Management acknowledged mixed economic signals and elevated market volatility, leading to a cautious approach [8] - The results underscore the strength of the business model, focusing on commercial momentum, cash generation, and maintaining a healthy balance sheet [9] - The company remains optimistic about its ability to navigate the complex environment and drive shareholder value [20] Other Important Information - The company ended the quarter with excess capital of approximately $150 million and a risk-based capital (RBC) ratio of 385% [18] - Approximately $400 million of debt was repaid in February, bringing the leverage ratio within target range [19] Q&A Session Summary Question: Insights on wealth earnings and margin guidance - Management noted that spread-based assets were higher than expected, but they anticipate moderation moving forward [26] Question: Details on voluntary reserves and loss ratio expectations - Reserves were increased due to economic uncertainty, with expectations for a high 40s loss ratio [32] Question: Clarification on stop-loss estimated loss ratio - The estimated loss ratio of 87% for the 2025 cohort is based on improved pricing and risk selection practices [41] Question: Update on voluntary business growth - The company experienced slower top-line growth due to large wins in the previous year not repeating, but the pipeline remains strong [50][52] Question: Free cash flow and earnings outlook - Management indicated that while they are not providing specific guidance, the previous estimate of $8 per share remains a reasonable starting point [59] Question: Impact of severance on expenses - Severance costs were part of ongoing expense management, with no significant future severance expected [105] Question: Investment management net inflows - Net inflows were broad-based across various channels and products, with no outsized mandates driving the results [80]

Core Insights - Techne (TECH) reported revenue of $316.18 million for the quarter ended March 2025, reflecting a year-over-year increase of 4.2% and surpassing the Zacks Consensus Estimate by 0.30% [1] - The company's EPS was $0.56, up from $0.48 in the same quarter last year, resulting in an EPS surprise of 9.80% compared to the consensus estimate of $0.51 [1] Financial Performance - Organic Growth was reported at 6%, exceeding the average estimate of 5.2% from three analysts [4] - Organic Growth in Diagnostics and Genomics was 2%, below the two-analyst average estimate of 6.2% [4] - Organic Growth in Protein Sciences was 7%, significantly higher than the average estimate of 2.8% from two analysts [4] - Net Sales from intersegment revenue was -$0.74 million, worse than the average estimate of -$0.55 million, representing a year-over-year decline of 3.7% [4] - Net Sales in Protein Sciences reached $227.69 million, surpassing the average estimate of $224.75 million, with a year-over-year increase of 6.1% [4] - Net Sales in Diagnostics and Genomics were $89.23 million, slightly below the average estimate of $92.50 million, showing a year-over-year growth of 2% [4] Market Performance - Techne's shares have returned -2.2% over the past month, contrasting with the Zacks S&P 500 composite's increase of 10.6% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]